These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8773946)

  • 1. Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (RDS).
    Cosmi EV; La Torre R; Di Iorio R; Anceschi MM
    J Perinat Med; 1996; 24(2):191-3. PubMed ID: 8773946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience.
    Cosmi EV; La Torre R; Piazze JJ; Maranghi GL; Lerro N; Bianco D; Anceschi MM
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):135-9. PubMed ID: 9138955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL; Kuehl TJ
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
    Harker LC; Merritt TA; Edwards DK
    J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraamniotic surfactant supply as RDS prevention].
    Lisawa J; Pietrasik D; Zwoliński J; Gierowska-Bogusz B; Lewandowski L; Chazan B
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):255-60. PubMed ID: 15537270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment.
    Illia R; Solana C; Oliveri P; Toblli J; Imaz MU; Häbich D
    J Perinat Med; 2004; 32(4):354-8. PubMed ID: 15346823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-amniotic instillation of surfactants for the prevention of neonatal respiratory distress syndrome following preterm delivery.
    Agarwal N; Bathwal S; Kriplani A; Deorari A; Bhatla N
    Int J Gynaecol Obstet; 2016 Nov; 135(2):196-199. PubMed ID: 27594379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory distress syndrome, fetal pulmonary surfactant, and amniotic fluid phospholipid analysis.
    Wenk RE
    Clin Lab Med; 1981 Jun; 1(2):199-213. PubMed ID: 6896681
    [No Abstract]   [Full Text] [Related]  

  • 9. Antenatal modes of surfactant administration for RDS prevention: a review.
    Ostrzenski A; Radolinski B; Ostrzenska KM
    J Natl Med Assoc; 2006 Mar; 98(3):340-4. PubMed ID: 16573296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the demonstration of amniotic phosphatidylglycerol in pregnancy in diabetic women].
    Legras B; Audiau C; Clerc C; Ruelland A; Gobron S; Cloarec L
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(5):587-9. PubMed ID: 4067212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic treatment of very premature infants with human surfactant.
    Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M
    N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies.
    Curet LB; Tsao FH; Zachman RD; Olson RW; Henderson PA
    Int J Gynaecol Obstet; 1989 Oct; 30(2):105-8. PubMed ID: 2572479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of neonatal respiratory distress syndrome by intra-amniotic administration of pulmonary surfactant.
    Zhang JP; Wang YL; Wang YH; Zhang R; Chen H; Su HB
    Chin Med J (Engl); 2004 Jan; 117(1):120-4. PubMed ID: 14733787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
    Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
    Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal pulmonary surfactant induction by bromhexine metabolite 8.
    Lorenz U; Rüttgers H; Fux G; Kubli F
    Am J Obstet Gynecol; 1974 Aug; 119(8):1126-8. PubMed ID: 4408018
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with the Helena Fetal-Tek method of lecithin/sphingomyelin determination.
    Merwin MC; Wians FH; Heald JI; Ziaya PR
    Clin Chem; 1985 Nov; 31(11):1924-5. PubMed ID: 4053379
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of respiratory distress syndrome: Current view of fetal lung maturity studies.
    Hallman M; Teramo K; Kankaanpää K; Kulovich MV; Gluck L
    Ann Clin Res; 1980 Feb; 12(1):36-44. PubMed ID: 6990860
    [No Abstract]   [Full Text] [Related]  

  • 19. Amniotic fluid phosphatidylglycerol and phosphatidylcholine phosphorus as predictors of fetal lung maturity.
    Kogon DP; Oulton M; Gray JH; Liston RM; Luther ER; Peddle LJ; Young DC
    Am J Obstet Gynecol; 1986 Feb; 154(2):226-30. PubMed ID: 3946508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amniotic fluid shake test versus lecithin-sphingomyelin ratio in the antenatal prediction of respiratory distress syndrome.
    Szabó IM; Csaba IF; Drozgyik IA; Novák PF
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):260-3. PubMed ID: 578601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.